跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-DONEPEZIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-DONEPEZIL
Authorized
STANDARD
MINT-DONEPEZIL
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7993c76ea5e18767
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
7993c76ea5e18767
Drug Approval Canada Name
MINT-DONEPEZIL
Product Name
MINT-DONEPEZIL
Status
Marketed
Status Date
2019-06-11
Original Market Date
2019-06-11
Din
02408600
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:04.00
Atc Original
N06DA02 DONEPEZIL
Atc Name
n 06 da 02
Aig Number
0131548001
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
DONEPEZIL HYDROCHLORIDE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7993c76ea5e18767
Type
Standard
Back to Health Canada Approvals